TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 7608347
Drug: Group cognitive-behavioral
Normalized name: Streptococcus viridans group
Approvals — FDA: no, EMA: no, PMDA: no
Description: Group cognitive-behavioral therapy (CBT) for 12 weeks
Study: 25257616
Drug: Radial shock
Normalized name: methyl salicylate
DrugBank: Methyl salicylate (DB09543)
Approvals — FDA: yes, EMA: no, PMDA: no
Description: Radial shock wave therapy (RSWT) - four sessions, once weekly
Study: 9407259
Drug: Creatine monohydrate
Normalized name: Creatine Monohydrate
Approvals — FDA: no, EMA: no, PMDA: no
Description: Creatine monohydrate (21 g.day-1)
Study: 11113218
Drug: rt-PA treatment
Normalized name: rt-PA
DrugBank: Alteplase (DB00009)
Approvals — FDA: yes, EMA: no, PMDA: no
Description: rt-PA treatment within 0 to 90 minutes
Study: 11239184
Drug: rt-PA treatment
Normalized name: rt-PA
DrugBank: Alteplase (DB00009)
Approvals — FDA: yes, EMA: no, PMDA: no
Description: rt-PA treatment
Study: 27346078
Drug: Polydextrose at
Normalized name: Polydextrose
DrugBank: Polydextrose (DB14836)
Approvals — FDA: no, EMA: no, PMDA: no
Description: Polydextrose at 50 g (positive control, single-dose study)
Study: 7825998
Drug: Methylprednisolone treatment
Normalized name: Methylprednisolone
DrugBank: Methylprednisolone (DB00959)
Approvals — FDA: yes, EMA: no, PMDA: no
Description: Methylprednisolone treatment group
Study: 7787215
Drug: GRP infusion
Normalized name: Duo Fusion
DrugBank: Magnesium hydroxide (DB09104)
Approvals — FDA: yes, EMA: no, PMDA: no
Description: GRP infusion
Study: 24700254
Drug: Intranasal PH94B
Normalized name: influenza A virus (H1N1) antigen
Approvals — FDA: no, EMA: no, PMDA: no
Description: Intranasal PH94B
Study: 24405979
Drug: Combination of
Normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
Approvals — FDA: no, EMA: no, PMDA: no
Description: Combination of low dose aspirin (75 mg daily) and low-molecular-weight heparin
Study: 9022487
Drug: Low dose
Normalized name: Low Dose ASA
Approvals — FDA: no, EMA: no, PMDA: no
Description: Low dose aspirin (75 mg daily)
Study: 8089640
Drug: 250 mg
Normalized name: rutin 250 MG
Approvals — FDA: no, EMA: no, PMDA: no
Description: 250 mg of oral terbinafine once daily for 2 weeks
Study: 8089640
Drug: 500 mg
Normalized name: bran 500 MG
Approvals — FDA: no, EMA: no, PMDA: no
Description: 500 mg of oral griseofulvin once daily for 2 weeks
Study: 15142150
Drug: Desmopressin nasal
Normalized name: desmopressin nasal
Approvals — FDA: no, EMA: no, PMDA: no
Description: Desmopressin nasal spray
Study: 18588736
Drug: ganciclovir 10
Normalized name: Ganciclovir
DrugBank: Ganciclovir (DB01004)
Approvals — FDA: yes, EMA: no, PMDA: no
Description: ganciclovir 10 mg/kg bodyweight for 21 days
Study: 8819063
Drug: Conservative treatment
Normalized name: Hongo Killer Treatment
Approvals — FDA: no, EMA: no, PMDA: no
Description: Conservative treatment (Control)
Study: 21159786
Drug: Magnesium citrate
Normalized name: Magnesium Citrate
DrugBank: Magnesium (DB14513)
Approvals — FDA: yes, EMA: no, PMDA: no
Description: Magnesium citrate (500 mg elemental Mg/d)
Study: 10930898
Drug: Cisapride 10
Normalized name: cisapride 10 MG
Approvals — FDA: no, EMA: no, PMDA: no
Description: Cisapride 10 mg t.d.s. and 20 mg b.d. (in patients with abnormal baseline electrogastrograms)
Study: 22820371
Drug: Vitamin D
Normalized name: Vitamin D
DrugBank: Vitamin D (DB11094)
Approvals — FDA: no, EMA: no, PMDA: no
Description: Vitamin D (active vitamin D analog compounds); specific dosage and duration not mentioned.
Study: 8006401
Drug: Vasopressin plus
Normalized name: Vasopressin
DrugBank: Vasopressin (DB00067)
Approvals — FDA: yes, EMA: no, PMDA: no
Description: Vasopressin plus transdermal nitroglycerin
Study: 3142634
Drug: Noxythiolin irrigation
Normalized name: noxythiolin Irrigation Product
Approvals — FDA: no, EMA: no, PMDA: no
Description: Noxythiolin irrigation (2.5% solution)
Study: 7874080
Drug: Conventional therapy
Normalized name: Monistat Simple Therapy
Approvals — FDA: no, EMA: no, PMDA: no
Description: Conventional therapy alone
Study: 19880463
Drug: One-year treatment
Normalized name: segesterone
DrugBank: Segesterone (DB14584)
Approvals — FDA: no, EMA: no, PMDA: no
Description: One-year treatment continuation
Study: 22710356
Drug: Beetroot (BR)
Normalized name: Respa-BR
Approvals — FDA: no, EMA: no, PMDA: no
Description: Beetroot (BR) beverage, 500 ml daily for 6 days
Study: 15237585
Drug: Alternating scheme
Normalized name: yellow fever virus strain 17D-204 live antigen
DrugBank: Yellow fever vaccine (DB10805)
Approvals — FDA: no, EMA: no, PMDA: no
Description: Alternating scheme (3 cycles of 5‐fluorouracil and leucovorin followed by pelvic radiotherapy and 3 weeks after radiation therapy, another 3 cycles of chemotherapy)
Study: 22387644
Drug: Gabapentin 600
Normalized name: gabapentin 600 MG
Approvals — FDA: no, EMA: no, PMDA: no
Description: Gabapentin 600 mg orally 2 hours prior to surgery
Study: 993925
Drug: High rate
Normalized name: high-density polyethylene
Approvals — FDA: no, EMA: no, PMDA: no
Description: High rate of intravenous infusion (10.3 ml/kg/hr)
Study: 2268740
Drug: Oyster shell
Normalized name: Oyster Shell
DrugBank: Ostrea edulis shell (DB14251)
Approvals — FDA: no, EMA: no, PMDA: no
Description: Oyster shell electrolysate (OSE) 900 mg/day
Study: 28780466
Drug: Cisplatin 80
Normalized name: Cisplatin
DrugBank: Cisplatin (DB00515)
Approvals — FDA: yes, EMA: no, PMDA: no
Description: Cisplatin 80 mg/m2 (GC80)
Study: 28726022
Drug: On-medication condition
Normalized name: selenium sulfide
DrugBank: Selenium Sulfide (DB00971)
Approvals — FDA: yes, EMA: no, PMDA: no
Description: On-medication condition
Study: 23718677
Drug: Dabigatran 150
Normalized name: dabigatran 150 mg oral capsule
Approvals — FDA: no, EMA: no, PMDA: no
Description: Dabigatran 150 mg twice daily
Study: 14739817
Drug: Basal-bolus group
Normalized name: Streptococcus viridans group
Approvals — FDA: no, EMA: no, PMDA: no
Description: Basal-bolus group (8 ml/h basal, 4 ml bolus)
Study: 8996292
Drug: Thrombolytic therapy
Normalized name: Monistat Simple Therapy
Approvals — FDA: no, EMA: no, PMDA: no
Description: Thrombolytic therapy for acute myocardial infarction
Study: 31867651
Drug: Immediate nicotine
Normalized name: Nicotine
DrugBank: Nicotine (DB00184)
Approvals — FDA: yes, EMA: no, PMDA: no
Description: Immediate nicotine reduction to 0.04 mg nicotine/g of tobacco
Study: 8318480
Drug: Topical ketanserin
Normalized name: ketanserin
DrugBank: Ketanserin (DB12465)
Approvals — FDA: no, EMA: no, PMDA: no
Description: Topical ketanserin 0.5%
Study: 20885202
Drug: Whole-body vibration
Normalized name: Insects (whole body), mite dermatophagoides farinae
Approvals — FDA: no, EMA: no, PMDA: no
Description: Whole-body vibration (WBV) treatment at frequencies of 30, 35, 40, or 50 Hz and amplitudes of 2-4 or 4-6 mm for 1 minute.
Study: 17900393
Drug: Group CBT
Normalized name: Streptococcus viridans group
Approvals — FDA: no, EMA: no, PMDA: no
Description: Group CBT (Cognitive Behavioral Therapy) targeting reduction of distress associated with hallucinations
Study: 12591053
Drug: Vitamin E
Normalized name: Vitamin E
DrugBank: Vitamin E (DB00163)
Approvals — FDA: yes, EMA: no, PMDA: no
Description: Vitamin E (800 IU) and Vitamin C (1000 mg) supplementation
Study: 10994883
Drug: Physical therapy
Normalized name: Monistat Simple Therapy
Approvals — FDA: no, EMA: no, PMDA: no
Description: Physical therapy only
Study: 334216
Drug: Nomifensine 75
Normalized name: nomifensine
DrugBank: Nomifensine (DB04821)
Approvals — FDA: yes, EMA: no, PMDA: no
Description: Nomifensine 75 mg with Clobazam 30 mg
Study: 24118113
Drug: Twice-daily biphasic
Normalized name: clindamycin
DrugBank: Clindamycin (DB01190)
Approvals — FDA: yes, EMA: no, PMDA: no
Description: Twice-daily biphasic insulin analogue (biphasic insulin aspart 70/30, biphasic insulin aspart 30)
Study: 7123952
Drug: Beta-methyl-digoxin (BMD)
Normalized name: Digoxin
DrugBank: Digoxin (DB00390)
Approvals — FDA: yes, EMA: no, PMDA: no
Description: Beta-methyl-digoxin (BMD) 0.5 mg
Study: 11028253
Drug: All doses
Normalized name: All Clear
DrugBank: Ethanol (DB00898)
Approvals — FDA: yes, EMA: no, PMDA: no
Description: All doses of methylphenidate HCl
Study: 3522770
Drug: Weekly doses
Normalized name: selinexor
DrugBank: Selinexor (DB11942)
Approvals — FDA: yes, EMA: yes, PMDA: no
Description: Weekly doses of 900 mg of rifampin plus daily doses of 100 mg of dapsone
Study: 21518554
Drug: Anti-thymocyte globulin
Normalized name: ANTI-THYMOCYTE GLOBULIN
DrugBank: Antilymphocyte immunoglobulin (horse) (DB09312)
Approvals — FDA: no, EMA: no, PMDA: no
Description: Anti-thymocyte globulin (ATG) (9 mg/kg) given 2 hours before kidney transplantation
Study: 31053134
Drug: Weekly incremental
Normalized name: tobramycin
DrugBank: Tobramycin (DB00684)
Approvals — FDA: yes, EMA: yes, PMDA: no
Description: Weekly incremental reductions in oral corticosteroid (OCS) dose
Study: 29486796
Drug: Deworming treatment
Normalized name: Hongo Killer Treatment
Approvals — FDA: no, EMA: no, PMDA: no
Description: Deworming treatment
Study: 24858376
Drug: 4 g
Normalized name: CTX4 Gel
Approvals — FDA: no, EMA: no, PMDA: no
Description: 4 g TRP-rich protein hydrolysate
Study: 30907817
Drug: Control group
Normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
Approvals — FDA: no, EMA: no, PMDA: no
Description: Control group (no heparin dose)
Study: 29275371
Drug: Different dual
Normalized name: Tums Dual Action
DrugBank: Alginic acid (DB13518)
Approvals — FDA: no, EMA: no, PMDA: no
Description: Different dual antiplatelet therapy durations and stent types
Study: 9473217
Drug: Oral hydroxyurea
Normalized name: Hydroxyurea
DrugBank: Hydroxyurea (DB01005)
Approvals — FDA: no, EMA: no, PMDA: no
Description: Oral hydroxyurea (80 mg/kg every 3 days)
Study: 9473217
Drug: Intravenous hydroxyurea
Normalized name: Hydroxyurea
DrugBank: Hydroxyurea (DB01005)
Approvals — FDA: no, EMA: no, PMDA: no
Description: Intravenous hydroxyurea (2000 mg as a 30-minute infusion)
Study: 12118641
Drug: Acupuncture treatment
Normalized name: Hongo Killer Treatment
Approvals — FDA: no, EMA: no, PMDA: no
Description: Acupuncture treatment during labour
Study: 30358831
Drug: Control capsule
Normalized name: Azo Men Bladder Control Capsules(obs)
DrugBank: Chloroxylenol (DB11121)
Approvals — FDA: yes, EMA: no, PMDA: no
Description: Control capsule (flavanol-free)
Study: 9505567
Drug: Granulocyte colony-stimulating
Normalized name: Granulocyte colony-stimulating factor lenograstim
DrugBank: Lenograstim (DB13144)
Approvals — FDA: no, EMA: no, PMDA: no
Description: Granulocyte colony-stimulating factor (G-CSF) and granulocyte-macrophage colony-stimulating factor (GM-CSF)
Study: 19819634
Drug: 1 mg
Normalized name: biotin 1 MG
Approvals — FDA: no, EMA: no, PMDA: no
Description: 1 mg kg(‐1) tramadol + 30 min later 0.05 mg kg(‐1) midazolam + 2 mg kg(‐1) ketamine
Study: 11779098
Drug: Control group
Normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
Approvals — FDA: no, EMA: no, PMDA: no
Description: Control group (no r‐HuEPO treatment)
Study: 30188953
Drug: Short-acting beta-agonists
Normalized name: Short-acting sulfonamides
Approvals — FDA: no, EMA: no, PMDA: no
Description: Short-acting beta-agonists (SABAs)
Study: 30876431
Drug: Active tDCS
Normalized name: Activated Charcoal
DrugBank: Activated charcoal (DB09278)
Approvals — FDA: no, EMA: no, PMDA: no
Description: Active tDCS (2 mA for 30 s) combined with upper limb physical therapy (20 min passive movement + 20 min active mini-bike) for 10 sessions.
Study: 29944604
Drug: Ketone ester
Normalized name: Ketonal
Approvals — FDA: no, EMA: no, PMDA: no
Description: Ketone ester (KE) supplement (750 mg·kg)
Study: 11155152
Drug: Interferon-alpha (IFN-alpha)
Normalized name: Interferon alpha-2B
DrugBank: Interferon alfa-2b (DB00105)
Approvals — FDA: yes, EMA: no, PMDA: no
Description: Interferon-alpha (IFN-alpha) at 3 MU thrice weekly (TIW) for 12 months
Study: 30648919
Drug: PCV15 Formulation
Normalized name: Hep B, unspecified formulation
Approvals — FDA: no, EMA: no, PMDA: no
Description: PCV15 Formulation B
Study: 26319158
Drug: Reuptake inhibitor
Normalized name: Dopamine reuptake inhibitor
Approvals — FDA: no, EMA: no, PMDA: no
Description: Reuptake inhibitor antidepressant medication (MED)
Study: 30521662
Drug: Short dental
Normalized name: short ragweed pollen extract Sublingual Tablet [Ragwitek]
Approvals — FDA: no, EMA: no, PMDA: no
Description: Short dental implants
Study: 22401329
Drug: Weekly automated
Normalized name: tobramycin
DrugBank: Tobramycin (DB00684)
Approvals — FDA: yes, EMA: yes, PMDA: no
Description: Weekly automated telephone self-management (ATSM) support with nurse care management
Study: 1971504
Drug: Interferon-alpha 18
Normalized name: Interferon alpha-2B
DrugBank: Interferon alfa-2b (DB00105)
Approvals — FDA: yes, EMA: no, PMDA: no
Description: Interferon-alpha 18 million U/d with zidovudine 100 mg every 4 hours
Study: 1971504
Drug: Interferon-alpha 9
Normalized name: Interferon alpha-2B
DrugBank: Interferon alfa-2b (DB00105)
Approvals — FDA: yes, EMA: no, PMDA: no
Description: Interferon-alpha 9 million U/d with zidovudine 100 or 200 mg every 4 hours
Study: 1971504
Drug: Combined therapy
Normalized name: REGN10933+REGN10987 combination therapy
DrugBank: Anti-SARS-CoV-2 REGN-COV2 (DB15691)
Approvals — FDA: no, EMA: no, PMDA: no
Description: Combined therapy with interferon-alpha and zidovudine
Study: 26457099
Drug: Olea ointment
Normalized name: Olea europaea pollen
DrugBank: Olea europaea pollen (DB10378)
Approvals — FDA: no, EMA: no, PMDA: no
Description: Olea ointment
Study: 7639972
Drug: Oral ganciclovir
Normalized name: Ganciclovir
DrugBank: Ganciclovir (DB01004)
Approvals — FDA: yes, EMA: no, PMDA: no
Description: Oral ganciclovir 500 mg six times daily
Study: 19061203
Drug: Active treatment
Normalized name: Activated Charcoal
DrugBank: Activated charcoal (DB09278)
Approvals — FDA: no, EMA: no, PMDA: no
Description: Active treatment doses (specific doses not mentioned)
Study: 1313951
Drug: Guar gum
Normalized name: Guar Gum
DrugBank: Guar gum (DB13446)
Approvals — FDA: no, EMA: no, PMDA: no
Description: Guar gum (mean of 11.2 g per day) for 3 months
Study: 12631592
Drug: Neoadjuvant therapy
Normalized name: Monistat Simple Therapy
Approvals — FDA: no, EMA: no, PMDA: no
Description: Neoadjuvant therapy with docetaxel plus doxorubicin or paclitaxel
Study: 27977721
Drug: Miconazole nitrate
Normalized name: Miconazole Nitrate
DrugBank: Miconazole (DB01110)
Approvals — FDA: yes, EMA: no, PMDA: yes
Description: Miconazole nitrate mucoadhesive tablets (10 mg) once daily for 14 days
Study: 27514411
Drug: Ulinastatin treatment
Normalized name: Hongo Killer Treatment
Approvals — FDA: no, EMA: no, PMDA: no
Description: Ulinastatin treatment group
Study: 2919769
Drug: No H2-antagonist
Normalized name: NO
DrugBank: Nitric Oxide (DB00435)
Approvals — FDA: yes, EMA: no, PMDA: no
Description: No H2-antagonist (Control)
Study: 17905178
Drug: Insulin Aspart
Normalized name: Insulin Aspart
DrugBank: Insulin aspart (DB01306)
Approvals — FDA: yes, EMA: yes, PMDA: yes
Description: Insulin Aspart (IAsp)
Study: 7049099
Drug: Hypothermic potassium
Normalized name: Potassium
DrugBank: Potassium (DB14500)
Approvals — FDA: no, EMA: no, PMDA: no
Description: Hypothermic potassium cardioplegia (cold crystalloid solution with 25 mEq/L potassium chloride)
Study: 31923099
Drug: Keto acid
Normalized name: Branched-chain alpha-keto acid dehydrogenase
Approvals — FDA: no, EMA: no, PMDA: no
Description: Keto acid (KA) supplement (0.1 g/kg/day)
Study: 27896411
Drug: Intravenous lidocaine
Normalized name: Lidocaine
DrugBank: Lidocaine (DB00281)
Approvals — FDA: yes, EMA: no, PMDA: no
Description: Intravenous lidocaine (2 mg/kg followed by continuous infusions of 3 mg/kg/h)
Study: 15644016
Drug: Nicotine replacement
Normalized name: Nicotine
DrugBank: Nicotine (DB00184)
Approvals — FDA: yes, EMA: no, PMDA: no
Description: Nicotine replacement therapy for dependent smokers
Study: 26908742
Drug: Single dose
Normalized name: Citrucel Single Dose Packets (Orange)
Approvals — FDA: no, EMA: no, PMDA: no
Description: Single dose of the live attenuated tetravalent dengue vaccine TV003
Study: 20306535
Drug: Olive oil
Normalized name: Olive Oil
DrugBank: Olive oil (DB09567)
Approvals — FDA: no, EMA: no, PMDA: no
Description: Olive oil capsules (656 mg daily) - Control
Study: 19375519
Drug: Oral mesalamine
Normalized name: Mesalamine
DrugBank: Mesalazine (DB00244)
Approvals — FDA: yes, EMA: no, PMDA: no
Description: Oral mesalamine 2 g once daily
Study: 26414912
Drug: one tablet
Normalized name: Hydone Tablet
Approvals — FDA: no, EMA: no, PMDA: no
Description: one tablet daily (seven/week)
Study: 17924872
Drug: 5 g
Normalized name: 15 g/31 g
Approvals — FDA: no, EMA: no, PMDA: no
Description: 5 g placebo (OGTT(control))
Study: 24446385
Drug: Exogenous insulin
Normalized name: INSULIN
DrugBank: Insulin beef (DB09456)
Approvals — FDA: yes, EMA: no, PMDA: no
Description: Exogenous insulin (biphasic insulin aspart) administered in relation to meals
Study: 17638699
Drug: 75 mg
Normalized name: talc 75 MG
Approvals — FDA: no, EMA: no, PMDA: no
Description: 75 mg bevirimat
Study: 17638699
Drug: 150 mg
Normalized name: pectin 150 MG
Approvals — FDA: no, EMA: no, PMDA: no
Description: 150 mg bevirimat
Study: 6418506
Drug: mannitol solution
Normalized name: Mannitol
DrugBank: Mannitol (DB00742)
Approvals — FDA: yes, EMA: no, PMDA: no
Description: mannitol solution
Study: 11673036
Drug: Subconjunctival administration
Normalized name: polidocanol
DrugBank: Polidocanol (DB06811)
Approvals — FDA: yes, EMA: no, PMDA: no
Description: Subconjunctival administration of 20 mg vancomycin
Study: 9037131
Drug: TSH suppressive
Normalized name: TSH-releasing hormone
DrugBank: Protirelin (DB09421)
Approvals — FDA: yes, EMA: no, PMDA: no
Description: TSH suppressive treatment
Study: 3061717
Drug: Captopril administration
Normalized name: Captopril
DrugBank: Captopril (DB01197)
Approvals — FDA: yes, EMA: no, PMDA: no
Description: Captopril administration in the supine position
Study: 21961644
Drug: Five days
Normalized name: fivehorn smotherweed pollen extract
DrugBank: Bassia hyssopifolia pollen (DB10941)
Approvals — FDA: no, EMA: no, PMDA: no
Description: Five days oral course of Co-Amoxiclav postoperatively
Study: 31479549
Drug: Etanercept 50
Normalized name: etanercept 50 MG/ML
Approvals — FDA: no, EMA: no, PMDA: no
Description: Etanercept 50 mg twice weekly
Study: 7191300
Drug: triamterene preparation
Normalized name: Triamterene
DrugBank: Triamterene (DB00384)
Approvals — FDA: yes, EMA: no, PMDA: no
Description: triamterene preparation 1
Study: 31963636
Drug: Oral piercings
Normalized name: benzalkonium
DrugBank: Benzalkonium (DB11105)
Approvals — FDA: yes, EMA: no, PMDA: no
Description: Oral piercings
Study: 17242102
Drug: Granisetron 3
Normalized name: granisetron 3 MG
Approvals — FDA: no, EMA: no, PMDA: no
Description: Granisetron 3 mg IV
Study: 14705234
Drug: Tramadol 37.5
Normalized name: ACETAMINOPHEN 325MG/TRAMADOL 37.5MG TAB
Approvals — FDA: no, EMA: no, PMDA: no
Description: Tramadol 37.5 mg/acetaminophen 325 mg (tramadol/APAP)
Study: 2966552
Drug: Low-dose isradipine
Normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
Approvals — FDA: yes, EMA: no, PMDA: yes
Description: Low-dose isradipine (0.007 mg/kg)
Study: 2966552
Drug: High-dose isradipine
Normalized name: Isradipine
DrugBank: Isradipine (DB00270)
Approvals — FDA: yes, EMA: no, PMDA: no
Description: High-dose isradipine (0.015 mg/kg)
Study: 8866920
Drug: 200 mg
Normalized name: RNA 200 MG
Approvals — FDA: no, EMA: no, PMDA: no
Description: 200 mg trimethoprim + 200 mg didanosine
Study: 24623104
Drug: Darbepoetin alfa
Normalized name: Darbepoetin Alfa
DrugBank: Darbepoetin alfa (DB00012)
Approvals — FDA: yes, EMA: no, PMDA: no
Description: Darbepoetin alfa 30 μg
Study: 18341417
Drug: Active laser
Normalized name: Activated Charcoal
DrugBank: Activated charcoal (DB09278)
Approvals — FDA: no, EMA: no, PMDA: no
Description: Active laser treatment (810-nm Ga-Al-As laser, 60 mW, 1.8 J per point, 14.4 J per session, 12 sessions over 8 weeks)
Study: 18563956
Drug: Intramuscular aripiprazole
Normalized name: Aripiprazole
DrugBank: Aripiprazole (DB01238)
Approvals — FDA: yes, EMA: yes, PMDA: yes
Description: Intramuscular aripiprazole (doses from 1 mg to 45 mg)
Study: 12221387
Drug: Professional oral
Normalized name: Dentek Professional Oral Care Kit
Approvals — FDA: no, EMA: no, PMDA: no
Description: Professional oral health care (POHC)
Study: 31096977
Drug: Control program
Normalized name: ZO Skin Health Pigment Control Program Plus Hydroquinone KIT
Approvals — FDA: no, EMA: no, PMDA: no
Description: Control program (monthly healthy lifestyle education-only)
Study: 28666848
Drug: propofol 25
Normalized name: Propofol
DrugBank: Propofol (DB00818)
Approvals — FDA: yes, EMA: no, PMDA: no
Description: propofol 25 mcg/kg/h + lidocaine 1 mg/kg/h
Study: 28666848
Drug: propofol 50
Normalized name: propofol 500 MG in 50 ML Injection
Approvals — FDA: no, EMA: no, PMDA: no
Description: propofol 50 mcg/kg/h
Study: 29499855
Drug: PF-03463275 20
Normalized name: acetylcysteine
DrugBank: Acetylcysteine magnesium (DB14080)
Approvals — FDA: yes, EMA: no, PMDA: no
Description: PF-03463275 20 mg twice a day
Study: 29499855
Drug: PF-03463275 60
Normalized name: codeine
DrugBank: Codeine (DB00318)
Approvals — FDA: yes, EMA: no, PMDA: no
Description: PF-03463275 60 mg twice a day
Study: 27147900
Drug: Three-weekly paclitaxel
Normalized name: Paclitaxel
DrugBank: Paclitaxel (DB01229)
Approvals — FDA: yes, EMA: yes, PMDA: yes
Description: Three-weekly paclitaxel (175 mg/m²)
Study: 28647788
Drug: 10 mg
Normalized name: biotin 10 MG
Approvals — FDA: no, EMA: no, PMDA: no
Description: 10 mg IV-dexamethasone (group dexa)
Study: 19035877
Drug: 400 microg
Normalized name: Fentanyl 400 microgram buccal film
Approvals — FDA: no, EMA: no, PMDA: no
Description: 400 microg inhaled salbutamol via spacer device (corrected for heart rate)
Study: 19035877
Drug: 2.5 mg
Normalized name: biotin 2.5 MG
Approvals — FDA: no, EMA: no, PMDA: no
Description: 2.5 mg nebulized salbutamol (corrected for heart rate)
Study: 15663493
Drug: Vitamin C
Normalized name: Vitamin C
DrugBank: Sodium ascorbate (DB14482)
Approvals — FDA: no, EMA: no, PMDA: no
Description: Vitamin C (2000 mg) and Vitamin E (800 IU) daily for 7 days prior to cryotherapy
Study: 2969930
Drug: Amlodipine 10
Normalized name: amlodipine 10 MG
Approvals — FDA: no, EMA: no, PMDA: no
Description: Amlodipine 10 mg/day
Study: 26763498
Drug: Written Exposure
Normalized name: Bacillus anthracis strain V770-NP1-R antigens
DrugBank: Anthrax vaccine (DB11003)
Approvals — FDA: no, EMA: no, PMDA: no
Description: Written Exposure Treatment (WET) for PTSD
Study: 21559793
Drug: Inhalation anesthesia
Normalized name: Gelato Anesthetic
Approvals — FDA: no, EMA: no, PMDA: no
Description: Inhalation anesthesia (SEV)
Study: 25119509
Drug: Multidisciplinary treatment
Normalized name: Hongo Killer Treatment
Approvals — FDA: no, EMA: no, PMDA: no
Description: Multidisciplinary treatment as usual without PMT
Study: 21293087
Drug: Losartan potassium
Normalized name: Losartan Potassium
DrugBank: Losartan (DB00678)
Approvals — FDA: yes, EMA: no, PMDA: no
Description: Losartan potassium (LOS) 50 mg for 4 weeks, then LOS 100 mg for 4 weeks (n = 469)
Study: 11083963
Drug: Nebulized ipratropium
Normalized name: Ipratropium
DrugBank: Ipratropium (DB00332)
Approvals — FDA: yes, EMA: no, PMDA: no
Description: Nebulized ipratropium bromide (250 mg per dose) plus nebulized salbutamol (0.2 mg/kg) and oral steroids (1 mg/kg)
Study: 3092656
Drug: Enprostil 35
Normalized name: enprostil
DrugBank: Enprostil (DB13824)
Approvals — FDA: no, EMA: no, PMDA: no
Description: Enprostil 35 micrograms twice daily
Study: 26496767
Drug: Insulin tolerance
Normalized name: INSULIN
DrugBank: Insulin beef (DB09456)
Approvals — FDA: yes, EMA: no, PMDA: no
Description: Insulin tolerance test (ITT)